BALSA LM; SOLERNO L; RODRIGUEZ MR; PARAJON B; GONZALEZ AC; ALONSO DF; GARONA J; LEON I

Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models

Chemico-Biological Interactions; Año: 2023 vol. 384

CARDAMA G; BUCCI P; LEMOS J; LLAVONA C; BENAVENTE M; HELLMEN E; FARA ML; MEDRANO E; SPITZER E; DEMARCO I; SABELLA P; GARONA J; ALONSO DF

In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma

Animals; Año: 2023 vol. 13

CARDAMA, GEORGINA A.; MAGGIO, JULIAN; VALDEZ CAPUCCINO, LUCAS; GONZALEZ, NAZARENO; MATILLER, VALENTINA; ORTEGA, HUGO H.; PEREZ, GERMAN R.; DEMARCO, IGNACIO A.; SPITZER, EDUARDO; GOMEZ, DANIEL E.; LORENZANO MENNA, PABLO; ALONSO, DANIEL F.

Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models

Cancers; Año: 2022 vol. 14

TORO, AYELEN; LAGE-VICKERS, SOFIA; BIZZOTTO, JUAN; VILICICH, FELIPE; SABATER, AGUSTINA; PASCUAL, GASTON; LEDESMA-BAZAN, SABRINA; SANCHIS, PABLO; RUIZ, MARIA SOL; AREVALO, ANA PAULA; PORFIDO, JORGE L.; ABBATE, MERCEDES; SENIUK, ROCIO; LABANCA, ESTEFANIA; ANSELMINO, NICOLAS; NAVONE, NORA M.; ALONSO, DANIEL F.; VAZQUEZ, ELBA; CRISPO, MARTINA; COTIGNOLA, JAVIER; GUERON, GERALDINE

Pin-Pointing the Key Hubs in the IFN-γ Pathway Responding to SARS-CoV-2 Infection

Viruses; Año: 2022 vol. 14

SOLERNÓ, LUISINA M.; SOBOL, NATASHA T.; GOTTARDO, MARÍA F.; CAPOBIANCO, CARLA S.; FERRERO, MAXIMILIANO R.; VÁSQUEZ, LILIANA; ALONSO, DANIEL F.; GARONA, JUAN

Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy

Scientific Reports; Año: 2022 vol. 12

ALONSO, DANIEL F.; TURIC, ESTEBAN; GARONA, JUAN

Desmopressin in canine mammary carcinoma: Comments on the importance of the administration route

VETERINARY AND COMPARATIVE ONCOLOGY; Año: 2021 vol. 19 p. 409 - 410

KROLEWIECKI, ALEJANDRO; LIFSCHITZ, ADRIÁN; MORAGAS, MATÍAS; TRAVACIO, MARINA; VALENTINI, RICARDO; ALONSO, DANIEL F.; SOLARI, RUBÉN; TINELLI, MARCELO A.; CIMINO, RUBÉN O.; ÁLVAREZ, LUIS; FLEITAS, PEDRO E.; CEBALLOS, LAURA; GOLEMBA, MARCELO; FERNÁNDEZ, FLORENCIA; FERNÁNDEZ DE OLIVEIRA, DIEGO; ASTUDILLO, GERMAN; BAECK, INÉS; FARINA, JAVIER; CARDAMA, GEORGINA A.; MANGANO, ANDREA; SPITZER, EDUARDO; GOLD, SILVIA; LANUSSE, CARLOS

Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial

EClinicalMedicine; Año: 2021 vol. 37

KROLEWIECKI, ALEJANDRO; LIFSCHITZ, ADRIÁN; MORAGAS, MATÍAS; TRAVACIO, MARINA; VALENTINI, RICARDO; ALONSO, DANIEL F.; SOLARI, RUBÉN; TINELLI, MARCELO A.; CIMINO, RUBÉN O.; ÁLVAREZ, LUIS; FLEITAS, PEDRO E.; CEBALLOS, LAURA; GOLEMBA, MARCELO; FERNÁNDEZ, FLORENCIA; DE OLIVEIRA, DIEGO FERNÁNDEZ; ASTUDILLO, GERMAN; BAECK, INÉS; FARINA, JAVIER; CARDAMA, GEORGINA A.; MANGANO, ANDREA; SPITZER, EDUARDO; GOLD, SILVIA; LANUSSE, CARLOS

Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]”

ECLINICALMEDICINE; Año: 2021 vol. 39

SOBOL, NATASHA; SOLERNÓ, LUISINA; BELTRÁN, BRADY; VÁSQUEZ, LILIANA; RIPOLL, GISELLE; GARONA, JUAN; ALONSO, DANIEL

Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2‑expressing human osteosarcoma

Experimental and Therapeutic Medicine; Año: 2021 vol. 21

ROCIO SOLEDAD, GARCIA-LAZARO; LORENA GISEL, CALIGIURI; NORAILYS, LORENZO; HUMBERTO, LAMDAN; DANIEL FERNANDO, ALONSO; HERNAN GABRIEL, FARINA

Yerba Mate Modulates Tumor Cells Functions Involved in Metastasis in Breast Cancer Models

Frontiers in Pharmacology; Año: 2021 vol. 12

SEGATORI, VALERIA INÉS; GARONA, JUAN; CALIGIURI, LORENA GRISEL; BIZZOTTO, JUAN; LAVIGNOLLE, ROSARIO; TORO, AYELÉN; SANCHIS, PABLO; SPITZER, EDUARDO; KROLEWIECKI, ALEJANDRO; GUERON, GERALDINE; ALONSO, DANIEL FERNANDO

Effect of ivermectin and atorvastatin on nuclear localization of importin alpha and drug target expression profiling in host cells from nasopharyngeal swabs of sars‐cov‐2‐ positive patients

Viruses; Año: 2021 vol. 13

ISEAS, SOLEDAD; ROCA, ENRIQUE L.; OCONNOR, JUAN M.; ELETA, MARTIN; SANCHEZ-LUCEROS, ANALIA; DI LEO, DANIELA; TINELLI, MARCELO; FARA, MARIA L.; SPITZER, EDUARDO; DEMARCO, IGNACIO A.; RIPOLL, GISELLE V.; PIFANO, MARINA; GARONA, JUAN; ALONSO, DANIEL F.

Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial

INVESTIGATIONAL NEW DRUGS; Año: 2020 vol. 38 p. 1580 - 1587

GARONA, JUAN; PIFANO, MARINA; RIPOLL, GISELLE; ALONSO, DANIEL F.

Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent

VITAMINS AND HORMONES SERIES; Año: 2020 vol. 113 p. 259 - 289

RIPOLL, GISELLE V.; PIFANO, MARINA; GARONA, JUAN; ALONSO, DANIEL F.

Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

Frontiers in Oncology; Año: 2020 vol. 9

LAMDAN, H.; GARCIA-LAZARO, R.S.; LORENZO, N.; CALIGIURI, L.G.; ALONSO, D.F.; FARINA, H.G.

Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin

Experimental Oncology; Año: 2020 vol. 42 p. 101 - 108

GARCIA-LAZARO, ROCIO S.; LAMDAN, HUMBERTO; CALIGIURI, LORENA G.; LORENZO, NORAILYS; BERENGENO, ANDREA L.; ORTEGA, HUGO H.; ALONSO, DANIEL F.; FARINA, HERNAN G.

In vitro and in vivo antitumor activity of Yerba Mate extract in colon cancer models

JOURNAL OF FOOD SCIENCE; Año: 2020 vol. 85 p. 2186 - 2197

ALONSO, DANIEL F.; FARINA, HERNÁN G.

Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS; Año: 2020 vol. 56

GOTTARDO, MARIA F.; CAPOBIANCO, CARLA S.; SIDABRA, JOHANNA E.; GARONA, JUAN; PERERA, YASSER; PEREA, SILVIO E.; ALONSO, DANIEL F.; FARINA, HERNAN G.

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization

Scientific Reports; Año: 2020 vol. 10

GARONA, JUAN; SOBOL, NATASHA T.; PIFANO, MARINA; SEGATORI, VALERIA I.; GOMEZ, DANIEL E.; RIPOLL, GISELLE V.; ALONSO, DANIEL F.

Preclinical efficacy of [V 4 Q 5 ]dDAVP, a second generation vasopressin analog, on metastatic spread and tumor-associated angiogenesis in colorectal cancer

Cancer Research and Treatment; Año: 2019 vol. 51 p. 438 - 450

GARONA, JUAN; SOBOL, NATASHA T.; SOLERNÓ, LUISINA M.; ALONSO, DANIEL F.

Potential Use of Desmopressin During Hepatic Resection for Colorectal Liver Metastases*

JOURNAL OF SURGICAL RESEARCH; Año: 2019

ASCHERO, ROSARIO; TORBIDONI, ANA; SAMPOR, CLAUDIA; LAURENT, VIVIANA; ZUGBI, SANTIAGO; WINTER, URSULA; LUBIENIECKI, FABIANA; ALONSO, DANIEL; SCHAIQUEVICH, PAULA; CHANTADA, GUILLERMO L.

Minimally disseminated disease and outcome in overt orbital retinoblastoma

PEDIATRIC BLOOD & CANCER; Año: 2019 vol. 66

CARDAMA, G.A.; ALONSO, D.F.; GONZALEZ, N.; MAGGIO, J.; GOMEZ, D.E.; ROLFO, C.; MENNA, P.L

Relevance of small GTPase Rac1 pathway in drug and radio-resistance mechanisms: Opportunities in cancer therapeutics

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; Año: 2018 vol. 124 p. 29 - 36

PIFANO, MARINA; GARONA, JUAN; SOBOL, NATASHA T; ALBERTÓ, MARINA; ALONSO, DANIEL F; RIPOLL, GISELLE V

Search of vasopressin analogs with antiproliferative activity on small-cell lung cancer: drug design based on two different approaches

FUTURE MEDICINAL CHEMISTRY; Año: 2018

SEGATORI, VALERIA I.; CUELLO, HÉCTOR A.; GULINO, CYNTHIA A.; ALBERTÓ, MARINA; VENIER, CECILIA; GUTHMANN, MARCELO D.; DEMARCO, IGNACIO A.; ALONSO, DANIEL F.; GABRI, MARIANO R.

Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients

CANCER IMMUNOLOGY IMMUNOTHERAPY; Año: 2018 vol. 67 p. 1285 - 1296

CHEVALIER, MERARI T.; GARONA, JUAN; SOBOL, NATASHA T.; FARINA, HERNAN G.; ALONSO, DANIEL F.; ÁLVAREZ, VERA A.

In vitro and in vivo evaluation of desmopressin-loaded poly(D,L-lactic-co-glycolic acid) nanoparticles for its potential use in cancer treatment

NANOMEDICINE; Año: 2018 vol. 13 p. 2835 - 2849

TORBIDONI, ANA V.; SAMPOR, CLAUDIA; LAURENT, VIVIANA E.; ASCHERO, ROSARIO; IYER, SAIPRIYA; ROSSI, JORGE; ALDERETE, DANIEL; ALONSO, DANIEL F.; SZIJAN, IRENE; CHANTADA, GUILLERMO L.

Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma

BRITISH JOURNAL OF OPHTHALMOLOGY; Año: 2018 vol. 102 p. 1597 - 1601

CUELLO HA; SEGATORI VI; ALBERTO M; GULINO C; ASCHERO R; CAMARERO S; GALLUZZO L; MADAUSS K; ALONSO DF; LUBIENIECKI F; GABRI MR

Aberrant O-glycosylation modulates aggressiveness in neuroblastoma

oncotarget; Año: 2018 vol. 9 p. 34176 - 34188

BENAVENT ACERO, FERNANDO; CAPOBIANCO, CARLA S.; GARONA, JUAN; CIRIGLIANO, STÉFANO M.; PERERA, YASSER; URTREGER, ALEJANDRO J.; PEREA, SILVIO E.; ALONSO, DANIEL F.; FARINA, HERNAN G.

CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models

LUNG CANCER; Año: 2017 vol. 107 p. 14 - 21

GARONA, JUAN; SOBOL, NATASHA T.; ALONSO, DANIEL F.

Impact of Perioperative Blood Transfusion on Survival Among Women With Breast Cancer

AMERICAN JOURNAL OF THERAPEUTICS; Año: 2017

PIFANO, MARINA; GARONA, JUAN; CAPOBIANCO, CARLA S.; GONZALEZ, NAZARENO; ALONSO, DANIEL F.; RIPOLL, GISELLE V.

Peptide agonists of vasopressin V2 receptor reduce expression of neuroendocrine markers and tumor growth in human lung and prostate tumor cells

Frontiers in Oncology; Año: 2017 vol. 7

GONZALEZ, N.; CARDAMA, G.A.; COMIN, M.J.; SEGATORI, V.I.; PIFANO, M.; ALONSO, D.F.; GOMEZ, D.E.; MENNA, P.L.

Pharmacological inhibition of Rac1-PAK1 axis restores tamoxifen sensitivity in human resistant breast cancer cells

CELLULAR SIGNALLING; Año: 2017 vol. 30 p. 154 - 161

GARONA, JUAN; SOBOL, NATASHA T.; ALONSO, DANIEL F.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer: Potential use of Perioperative Desmopressin to Reduce Allogenic Blood Transfusion Rates

JOURNAL OF GASTROINTESTINAL SURGERY : OFFICIAL JOURNAL OF THE SOCIETY FOR SURGERY OF THE ALIMENTARY TRACT.; Año: 2017 vol. 21 p. 1971 - 1973

GABRI MR; CACCIAVILLANO W; CHANTADA GL; ALONSO DF

Racotumomab for treating lung cancer and pediatric refractory malignancies

EXPERT OPINION ON BIOLOGICAL THERAPY; Año: 2016 vol. 16 p. 573 - 578

CUELLO HA; SEGATORI VI; ALBERTO M; PESCE A; ALONSO DF.; GABRI MR

Comparability of antibody-mediated cell killing activity between a proposed biosimilar RTXM83 and the originator rituximab

BIODRUGS; Año: 2016 vol. 30 p. 225 - 231

GARONA J; ALONSO DF

Peri-operative biology in primary breast cancer: selective targeting of vasopressin type 2 receptor using desmopressin as a novel therapeutic approach

BREAST CANCER RESEARCH AND TREATMENT; Año: 2016 vol. 158 p. 597 - 599

GARONA J; ALONSO DF

Urokinase exerts antimetastatic effects by dissociating clusters of circulating tumor cells

CANCER RESEARCH; Año: 2016 vol. 76 p. 4908 - 4908

ROSE A; ANDRE N; ROZADOS VR; MAINETTI LE; MARQUEZ MM; RICO MJ; SCHAIQUEVICH P; VILLARROEL M; GREGIANIN L; GRAUPERA JM; GARCIA WG; EPELMAN S; ALASINO C; ALONSO DF; CHANTADA GL; SCHAROVSKY OG

Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina

ecancermedicalscience; Año: 2016 vol. 10 p. 672 - 672

GARONA J; PIFANO M; PASTRIAN MB; GOMEZ DE; RIPOLL GV; ALONSO DF

Addition of vasopressin synthetic analogue [V4Q5]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models

CLINICAL & EXPERIMENTAL METASTASIS; Año: 2016 vol. 33 p. 589 - 600

LAURENT VE; TORBIDONI AV; SAMPOR C; OTTAVIANI D; VAZQUEZ V; GABRI MR; DE DAVILA MT; RAMIREZ ORTIZ MA; ALONSO C; ROSSI J; ALONSO DF; CHANTADA GL

Minimal disseminated disease in non-metastatic retinoblastoma with high-risk pathology features

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION; Año: 2016 vol. 134 p. 1374 - 1379

WEINBERG R; GRECCO MO; FERRO GS; SEIGELSHIFER DJ; PERRONI NV; TERRIER FJ; SANCHEZ LUCEROS A; MARONNA E; SANCHEZ MARULL R; FRAHM I; GUTHMANN MD; DI LEO D; SPITZER E; CICCIA GN; GARONA J; PIFANO M; TORBIDONI AV; GOMEZ DE; RIPOLL GV; GOMEZ DE; DEMARCO I; ALONSO DF

A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-D-arginine vasopressin) in breast cancer patients

Springerplus; Año: 2015 vol. 4 p. 428 - 428

SARDUY MR; GARCIA I; COCA MA; PERERA A; TORRES LA; VALENZUELA CM; BALADRON I; SOLARES M; REYES V; HERNANDEZ I; PERERA Y; MARTINEZ YM; MOLINA L; ANCIZAR JA; PRATS A; GONZALEZ L; CASACO CA; ACEVEDO BE; LOPEZ SAURA P; ALONSO DF; GOMEZ RE; PEREA SE

Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer

BRITISH JOURNAL OF CANCER; Año: 2015 vol. 112 p. 1636 - 1643

GARONA J; PIFANO M; ORLANDO U; PASTRIAN MB; IANNUCCI NB; ORTEGA HH; PODESTA E; GOMEZ DE; RIPOLL GV; ALONSO DF

The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models

INTERNATIONAL JOURNAL OF ONCOLOGY; Año: 2015 vol. 46 p. 2335 - 2345

ALONSO DF

Cirrhosis, von Willebrand factor (vWF) and the low incidence of metastatic malignancy in injured liver

EURASIAN JOURNAL OF MEDICINE; Año: 2015 vol. 47 p. 229 - 230

CACCIAVILLANO W; SAMPOR C; VENIER C; GABRI MR; DE DAVILA MT; GALLUZZO L; GUTHMANN MD; FAINBOIM L; ALONSO DF; CHANTADA GL

A Phase I study of the anti-idiotype vaccine racotumomab in neuroblastoma and other pediatric refractory malignancies

PEDIATRIC BLOOD & CANCER; Lugar: New York; Año: 2015 vol. 62 p. 2120 - 2124

TORBIDONI AV; SCURSONI AM; CAMARERO S; SEGATORI VI; GABRI MR; ALONSO DF; CHANTADA GL; DAVILA MT

Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours

ACTA OPHTHALMOLOGICA; Año: 2015 vol. 93 p. 294 - 300

TORBIDONI AV; LAURENT VE; SAMPOR C; OTTAVIANI D; VAZQUEZ V; GABRI MR; ROSSI J; DE DAVILA MT; ALONSO C; ALONSO DF; CHANTADA GL

Association of cone-rod homeobox transcription factor messenger RNA with pediatric metastatic retinoblastoma

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION; Lugar: Chicago; Año: 2015 vol. 133 p. 805 - 812

FERNANDEZ LARROSA P; RUIZ GRECO M; MENGUAL GOMEZ D; ALVARADO CV; PANELO LC; RUBIO MF; ALONSO DF; GOMEZ DE; COSTAS MA

RAC3 more than a nuclear receptor coactivator: A key inhibitor of senescence that is down-regulated in aging

Cell Death and Disease; Año: 2015 vol. 6 p. 1902 - 1902

GARONA J; ALONSO DF

Reciprocal interactions between tumor and endothelial cells: effects of selective vasopressin V2 receptor peptide agonists.

Cancer Cell and Microenvironment; Año: 2014 vol. 1 p. 1 - 5

CARDAMA GA; COMIN MJ; HORNOS L; GONZALEZ N; DEFELIPE L; TURJANSKI AG; ALONSO DF; GOMEZ DE; MENNA LP

Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY; Año: 2014 vol. 14 p. 840 - 841

BENAVENT ACERO FR; PERERA NEGRIN Y; ALONSO DF; PEREA SE; GOMEZ DE; FARINA HG

Mechanisms of Cellular Uptake, Intracellular Transportation, and Degradation of CIGB-300, a Tat-Conjugated Peptide, in Tumor Cell Lines

MOLECULAR PHARMACEUTICS; Lugar: Washington; Año: 2014

PASTRIAN MB ; GUZMÁN F; GARONA J; PIFANO M; RIPOLL GV; CASCONE O; CICCIA GN; ALBERICIO F; GÓMEZ DE; ALONSO DF; IANNUCCI NB

Structure-activity relationship of 1-desamino-D-arginine vasopressin as an antiproliferative agent on human vasopressin V2 receptor-expressing cancer cells.

MOLECULAR MEDICINE REPORTS; Año: 2014 vol. 9 p. 2568 - 2572

GARONA J; PIFANO M; SCURSONI AM; GOMEZ DE; ALONSO DF; RIPOLL GV

Insight into the Effect of the Vasopressin Analog Desmopressin on Lung Colonization by Mammary Carcinoma Cells in BALB/c Mice

ANTICANCER RESEARCH; Lugar: Kapandriti; Año: 2014 vol. 34 p. 4761 - 4765

CARDAMA GA; GONZALEZ N; CIARLANTINI M; DONADIO LG; COMIN MJ; ALONSO DF; LORENZANO MENNA P; GOMEZ DE

Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells

Oncotargets and Therapy; Año: 2014 vol. 7 p. 2021 - 2033

LAURENT VE ; SAMPOR C; SOLERNOU V ; ROSSI J; GABRI M; EANDI-EBERLE S; DE DAVILA MT; ALONSO DF; CHANTADA GL

Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA

EUROPEAN JOURNAL OF CANCER; Lugar: Amsterdam; Año: 2013 vol. 49 p. 2892 - 2899

GOMEZ DE; VÁZQUEZ AM; ALONSO DF; MACÍAS A

Anti-idiotype antibodies in cancer treatment.

Frontiers in Oncology; Año: 2013 vol. 3 p. 1 - 1

RIPOLL GV; GARONA J; PIFANO M; FARINA HG; GOMEZ DE; ALONSO DF

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model.

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 2013 vol. 142 p. 9 - 18

RIPOLL GV. ; ALONSO DF.

Implication of von Willebrand factor as a regulator of tumor cell metastasis: potential perioperative use of desmopressin and novel peptide analogs.

ACTA HAEMATOLOGICA; Año: 2013 vol. 129 p. 223 - 224

ORLANDO U; GARONA J; RIPOLL GV; MALOBERTI P; SOLANO AR; AVAGNINA A; GOMEZ DE; ALONSO DF; PODESTA E

The functional interaction between acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target

PLOS ONE; Lugar: San Francisco; Año: 2012 vol. 7 p. 40794 - 40794

ALONSO DF

Re: Effect of ADAM28 on Carcinoma Cell Metastasis by Cleavage of von Willebrand factor

JOURNAL OF THE NATIONAL CANCER INSTITUTE.; Lugar: Oxford; Año: 2012 vol. 104 p. 1917 - 1917

VAZQUEZ AM; HERNANDEZ AM; MACIAS A; MONTERO E; GOMEZ DE; ALONSO DF; GABRI MR; GOMEZ RE

Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing-gangliosides. Preclinical and clinical data

Frontiers in Oncology; Año: 2012 vol. 2 p. 150 - 150

SEGATORI VI; VAZQUEZ AM; GOMEZ DE; GABRI MR; ALONSO DF

Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer

Frontiers in Oncology; Año: 2012 vol. 2 p. 160 - 160

GUTHMANN MD; VENIER C; TOLEDO D; SEGATORI VI; ALONSO DF; FAINBOIM L; VAZQUEZ AM; OSTROWSKI H

Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3

Frontiers in Immunology; Año: 2012 vol. 3 p. 422 - 422

PERERA Y; COSTALES HC; DIAZ Y; REYES O; FARINA HG; MENDEZ L; GOMEZ RE; ACEVEDO BE; GOMEZ DE; ALONSO DF; PEREA SE

Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization

JOURNAL OF PEPTIDE SCIENCE : AN OFFICIAL PUBLICATION OF THE EUROPEAN PEPTIDE SOCIETY.; Lugar: Londres; Año: 2012 vol. 18 p. 215 - 223

SEGATORI VI; OTERO LL; FERNANDEZ LE; GOMEZ DE; ALONSO DF; GABRI MR

Antitumor protection by NGcGM3/VSSP vaccine against transfected B16 mouse melanoma cells overexpressing N-glycolylated gangliosides

IN VIVO; Año: 2012 vol. 26 p. 609 - 617

GOMEZ DE; ARMANDO RG; FARINA HG; LORENZANO MENNA P; CERRUDO C; GHIRINGHELLI PD; ALONSO DF

Telomere structure and telomerase in health and disease

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Atenas; Año: 2012 vol. 41 p. 1561 - 1569

GOMEZ DE; VAZQUEZ AM; ALONSO DF

Cancer antigen prioritization: a road map to work in defining vaccines against specific targets

Frontiers in Oncology; Año: 2012 vol. 2 p. 66 - 66

GOMEZ DE; ARMANDO RG; ALONSO DF

AZT as a telomerase inhibitor

Frontiers in Oncology; Año: 2012 vol. 2 p. 113 - 113

BLANCO R; RENGIFO E; CEDEÑO M; RENGIFO CE; ALONSO DF; CARR A

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System

ISRN Gastroenterology; Año: 2011 vol. 2011 p. 645641 - 645641

OTERO LL; ALONSO DF; CASTRO MA; CINAT G; GABRI MR; GOMEZ DE

Tissue factor as a novel marker for detection of circulating cancer cells

BIOMARKERS; Lugar: Londres; Año: 2011 vol. 16 p. 58 - 64

FARINA HG; BENAVENT ACERO F; PERERA Y; RODRIGUEZ A; PEREA SE; ACEVEDO BE; GOMEZ RE; ALONSO DF; GOMEZ DE

CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivo.

EXPERIMENTAL CELL RESEARCH; Lugar: Amsterdam ; Año: 2011 vol. 317 p. 1677 - 1688

SCURSONI AM; GALLUZZO L; CAMARERO S; LOPEZ J; LUBIENIECKI F; SAMPOR C; SEGATORI VI; GABRI MR; ALONSO DF; CHANTADA G; DAVILA MT

Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer

CLINICAL AND DEVELOPMENTAL IMMUNOLOGY; Lugar: New York; Año: 2011 vol. 2011 p. 245181 - 245181

IANNUCCI N; RIPOLL GV; GARONA J; CASCONE O; CICCIA GN; GOMEZ DE; ALONSO DF

Antiproliferative effect of 1-deamino-8-D-arginine vasopressin analogs on human breast cancer cells

Future Medicinal Chemistry; Año: 2011 vol. 3 p. 1987 - 1993

ALONSO DF; RIPOLL GV; GARONA J; IANNUCCI N; GOMEZ DE

Metastasis: recent discoveries and novel perioperative treatment strategies with particular interest in the hemostatic compound desmopressin

CURRENT PHARMACEUTICAL BIOTECHNOLOGY; Lugar: Oak Park; Año: 2011 vol. 12 p. 1974 - 1980

HERMO GA; FARINA HG; ALONSO DF; GOMEZ DE

Effect of atorvastatin in a case of feline multicentric lymphoma - Case report

ACTA VETERINARIA HUNGARICA; Lugar: Budapest; Año: 2011 vol. 59 p. 69 - 77

HERMO GA; TURIC E; ANGELICO D; SCURSONI AM; GOMEZ DE; GOBELLO C; ALONSO DF

Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade

JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION; Año: 2011 vol. 47 p. 21 - 27

PEREA SE; BALADRON I; GARCIA Y; GOMEZ DE; ALONSO DF; PERRIN P; RENAULT JY; SIGMAN H; HERRERA L; ACEVEDO BE

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

MOLECULAR AND CELLULAR BIOCHEMISTRY; Lugar: Berlin; Año: 2011 vol. 356 p. 45 - 50

LE FERNANDEZ; MR GABRI; M GUTHMANN; RE GOMEZ; S GOLD; DE GOMEZ; DF ALONSO

NGcGM3 ganglioside: a privileged target for cancer vaccines

CLINICAL AND DEVELOPMENTAL IMMUNOLOGY; Año: 2010 vol. 2010 p. 814397 - 814397

VE LAURENT; LL OTERO; V VAZQUEZ; S CAMARERO; MR GABRI; M LABRADA; DAVILA MT; G CHANTADA; DF ALONSO

Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma

MOLECULAR MEDICINE REPORTS; Año: 2010 vol. 3 p. 253 - 259

GV RIPOLL; J GARONA; G HERMO; DE GOMEZ; DF ALONSO

Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancer

ANTICANCER RESEARCH; Año: 2010 vol. 30 p. 5049 - 5054

PL MENNA; GA CARDAMA; MJ COMIN; DF ALONSO; DE GOMEZ

Rho GTPases as therapeutic targets in cancer and other human pathologies

MEDICINA (BUENOS AIRES); Año: 2010 vol. 70 p. 555 - 564

A RODRIGUEZ; HG FARINA; DF ALONSO; BE ACEVEDO; G PADRON; A MUSACCHIO; SE PEREA

Proteomic profile regulated by the anticancer peptide CIGB-300 in non-small cell lung cancer (NSCLC) cells

JOURNAL OF PROTEOME RESEARCH; Año: 2010 vol. 9 p. 5473 - 5483

D FUENTES; J AVELLANET; A GARCIA; N IGLESIAS; MR GABRI; ALONSO DF; AM VAZQUEZ; R PEREZ; E MONTERO

Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model

BREAST CANCER RESEARCH AND TREATMENT; Año: 2010 vol. 120 p. 379 - 389

AM SCURSONI; L GALLUZZO; S CAMARERO; N POZZO; MR GABRI; C MATEO; AM VAZQUEZ; DF ALONSO; MT DAVILA

Detection and characterization of N-glycolylated gangliosides in Wilms tumor by immunohistochemistry

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY; Año: 2010 vol. 13 p. 18 - 23

M LABRADA; M CLAVELL; Y BEBELAGUA; J LEON; DF ALONSO; MR GABRI; RC VELOSO; V VEREZ; LE FERNANDEZ

Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy

EXPERT OPINION ON BIOLOGICAL THERAPY; Año: 2010 vol. 10 p. 153 - 162

MR GABRI; LL OTERO; DE GOMEZ; DF ALONSO

Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH; Año: 2009 vol. 28 p. 146 - 146

P LORENZANO MENNA; RL PARERA; GA CARDAMA; DF ALONSO; DE GOMEZ; HG FARINA

Enhanced cytostatic activity of statins in mouse mammary carcinoma cells overexpressing β2-chimaerin

MOLECULAR MEDICINE REPORTS; Año: 2009 vol. 2 p. 97 - 102

V VAZQUEZ; L OTERO; V LAURENT; MR GABRI; DE GOMEZ; DF ALONSO

Molecular detection of minimal residual disease in melanoma and solid tumors

MEDICINA (BUENOS AIRES); Año: 2009 vol. 69 p. 181 - 190

AM SOLARES; DF ALONSO; L HERRERA; H SIGMAN; SE PEREA; BE ACEVEDO; P LOPEZ SAURA

Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

BMC CANCER; Año: 2009 vol. 9 p. 146 - 146

Y PERERA; HG FARINA; J GIL; A RODRIGUEZ; F BENAVENT ACERO; L CASTELLANOS; RE GOMEZ; BE ACEVEDO; DF ALONSO; SE PEREA

Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity

MOLECULAR CANCER THERAPEUTICS; Año: 2009 vol. 8 p. 1189 - 1196

VAZQUEZ V; OTERO LL; LAURENT VE; GABRI MR; GOMEZ DE; ALONSO DF

Molecular detection of minimal residual disease in melanoma and solid tumors.

MEDICINA (BUENOS AIRES); Año: 2008

RIPOLL GV; GIRON S; KRZYMUSKI M; HERMO GA; GOMEZ DE; ALONSO DF

Antitumor effects of desmopressin in combination with chemotherapeutic agents in a mouse model of breast cancer

ANTICANCER RESEARCH; Año: 2008 vol. 28 p. 2607 - 2611

PEREA SE; GOMEZ DE; GOMEZ RE; ALONSO DF; SIGMAN H; HERRERA L; ACEVEDO BE

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo

MOLECULAR AND CELLULAR BIOCHEMISTRY; Año: 2008 vol. 316 p. 163 - 167

HERMO GA; TORRES P; RIPOLL GV; SCURSONI AM; GOMEZ DE; ALONSO DF; GOBELLO C

Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: A pilot study

The Veterinary Journal; Año: 2008 vol. 178 p. 103 - 108

ALFONSO S; DIAZ RM; DE LA TORRE A; SANTIESTEBAN E; AGUIRRE F; PEREZ K; RODRIGUEZ JL; BARROSO MD; HERNANDEZ AM; TOLEDO D; GABRI MR; ALONSO DF; VIADA C; GOMEZ RE; SUAREZ E; VAZQUEZ AM; PEREZ R; MACIAS AE

1E10 Anti-Idiotype Vaccine in Non-Small Cell Lung Cancer: Experience in Stage IIIb/IV Patients

CANCER BIOLOGY & THERAPY; Año: 2008 vol. 6 p. 1847 - 1852

PERERA Y; FARINA HG; HERNANDEZ I; MENDOZA O; SERRANO JM; REYES O; GOMEZ DE; GOMEZ RE; ACEVEDO BE; ALONSO DF; PEREA SE

Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 2008 vol. 122 p. 57 - 62

GABRI MR; VAZQUEZ V; GIRON S; CASTRO MA; CINAT G; GOMEZ RE; SANTORO FM; GOMEZ DE; ALONSO DF

Molecular detection of circulating tyrosinase mRNA: Optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patients

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Año: 2008 vol. 21 p. 555 - 559

GARRIDO G; LORENZANO MENNA P; SANCHEZ B; BEAUSOLEIL I; ALONSO DF; PEREZ R; FERNANDEZ LE

T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies

CANCER IMMUNOLOGY IMMUNOTHERAPY; Año: 2007 vol. 56 p. 1701 - 1710

NENINGER E; DIAZ RM; DE LA TORRE A; RIVES R; DIAZ A; SAUREZ G; GABRI MR; ALONSO DF; WILKINSON B; ALFONSO AM; CROMBET T; PEREZ R; VAZQUEZ AM

Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial

CANCER BIOLOGY & THERAPY; Año: 2007 vol. 6 p. 145 - 150

DE GOMEZ; GV RIPOLL; S GIRON; DF ALONSO

Desmopressin and other synthetic vasopressin analogues in cancer treatment

BULLETIN DU CANCER; Año: 2006 vol. 93 p. 7 - 12

MR GABRI; Z MAZORRA; GV RIPOLL; C MESA; LE FERNANDEZ; DE GOMEZ; DF ALONSO

Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma model

CLINICAL CANCER RESEARCH; Año: 2006 vol. 12 p. 7092 - 7098

HG FARINA; M POMIES; DF ALONSO; DE GOMEZ

Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer

ONCOLOGY REPORTS; Año: 2006 vol. 16 p. 885 - 891

DE GOMEZ; GV RIPOLL; S GIRON; DF ALONSO

Desmopressin and other synthetic vasopressin analogues in cancer treatment

BULLETIN DU CANCER; Año: 2006 vol. 93 p. 7 - 12

GV RIPOLL; HG FARINA; H YOSHIJI; DE GOMEZ; DF ALONSO

Desmopressin reduces melanoma lung metastasis in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1

IN VIVO; Año: 2006 vol. 20 p. 881 - 885

PL MENNA; LY PECHE; DF ALONSO; DE GOMEZ

Role of ß2-chimaerin in the behaviour of murine mammary carcinoma cells in response to extracellular matrix components

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Año: 2005 vol. 15 p. 91 - 95

GUTHMANN MD; BITTON RJ; CARNERO AJ; GABRI MR; CINAT G; KOLIREN L; LEWI D; FERNANDEZ LE; ALONSO DF; GOMEZ DE; FAINBOIM L

Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity

JOURNAL OF IMMUNOTHERAPY; Año: 2004 vol. 27 p. 442 - 451

GUTHMANN MD; BITTON RJ; CARNERO AJ; GABRI MR; CINAT G; KOLIREN L; LEWI D; FERNANDEZ LE; ALONSO DF; GOMEZ DE; FAINBOIM L

Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity

JOURNAL OF IMMUNOTHERAPY; Año: 2004 vol. 27 p. 442 - 451

PEREA SE; REYES O; PUCHADES Y; MENDOZA O; VISPO NS; TORRENS I; SANTOS A; SILVA R; ACEVEDO BE; LOPEZ E; FALCON V; ALONSO DF

Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2)

CANCER RESEARCH; Año: 2004 vol. 64 p. 7127 - 7129

DE LORENZO MS; FARINA HG; ALONSO DF; GOMEZ DE

Role of protein kinase C-dependent signaling pathways in the antiangiogenic properties of nafoxidine

ANTICANCER RESEARCH; Año: 2004 vol. 24 p. 1737 - 1743

LORENZANO MENNA P; SKILTON G; COLUCCIO LESKOW F; ALONSO DF; GOMEZ DE; KAZANIETZ M

Inhibition of aggressiveness of metastatic mouse mammary carcinoma cells by the b2-chimaerin GAP domain

CANCER RESEARCH; Año: 2003 vol. 63 p. 2284 - 2291

FERNANDEZ LE; ALONSO DF; GOMEZ DE; VAZQUEZ AM

Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer

EXPERT REVIEW OF VACCINES; Año: 2003 vol. 2 p. 817 - 823

DE LORENZO MS; RIPOLL GV; YOSHIJI H; YAMAZAKI M; THORGEIRSSON UP; ALONSO DF; GOMEZ DE

Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1

IN VIVO; Año: 2003 vol. 17 p. 45 - 50

GABRI, MARIANO R.; RIPOLL, GISELLE V.; ALONSO, DANIEL F.; GÓMEZ, DANIEL E.

Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; Año: 2002 vol. 128 p. 669 - 677

FARINA HG; BUBLIK DR; ALONSO DF; GOMEZ DE

Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells

CLINICAL & EXPERIMENTAL METASTASIS; Lugar: Berlin; Año: 2002 vol. 19 p. 551 - 559

GIRON, SANTIAGO; TEJERA, AGUEDA M.; RIPOLL, GISELLE V.; GOMEZ, DANIEL E.; ALONSO, DANIEL F.

Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation

JOURNAL OF SURGICAL ONCOLOGY; Año: 2002 vol. 81 p. 38 - 44

BITTON RJ; GUTHMANN MD; GABRI MR; CARNERO AJ; ALONSO DF; FAINBOIM L; GOMEZ DE

Cancer Vaccines: An update with special focus on ganglioside antigens

ONCOLOGY REPORTS; Lugar: Atenas; Año: 2002 vol. 93 p. 267 - 276

VÁZQUEZ, ANA MARÍA; GABRI, MARIANO R.; HERNÁNDEZ, ANA MARÍA; ALONSO, DANIEL F.; BEAUSOLEIL, IRENE; GOMEZ, DANIEL E.; PÉREZ, ROLANDO

Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides

ONCOLOGY REPORTS; Año: 2000 vol. 7 p. 751 - 756

ALONSO DF; SKILTON G; FARIAS EF; BAL DE KIER JOFFE E; GOMEZ DE

Antimetastatic effect of desmopressin in a mouse mammary tumor model

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 1999 vol. 57 p. 271 - 275

ALONSO DF; FARINA HG; SKILTON G; GABRI MR; DE LORENZO MS; GOMEZ DE

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of mevalonate pathway of cholesterol synthesis

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 1998 vol. 50 p. 83 - 93

GOMEZ DE; ALONSO DF; YOSHIJI H; THORGEIRSSON UP

Tissue inhibitors of metalloproteinases; structure, regulation and biological functions

EUROPEAN JOURNAL OF CELL BIOLOGY; Año: 1997 vol. 74 p. 111 - 122

AGUIRRE GHISO, JULIO A.; ALONSO, DANIEL F.; FARÍAS, EDUARDO F.; BAL DE KIER JOFFÉ, ELISA

Overproduction of urokinase-type plasminogen activator is regulated by phospholipase D- and protein kinase C-dependent pathways in murine mammary adenocarcinoma cells

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH; Año: 1997 vol. 1356 p. 171 - 184

ALONSO, DANIEL F.; FARÍAS, EDUARDO F.; URTREGER, ALEJANDRO; LADEDA, VIRGINIA; VIDAL, MARÍA DEL CARMEN C.; JOFFÉ, ELISA BAL DE KIER

Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma

JOURNAL OF SURGICAL ONCOLOGY; Lugar: New York; Año: 1996 vol. 62 p. 288 - 297